Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
had a lot of troubles swallowing; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 77-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Dec2023 as dose 1, single (Batch/Lot number: unknown) at the age of 76 years for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure high" (ongoing). Concomitant medication(s) included: ALDACTONE [SPIRONOLACTONE] taken for hypertension; PREVACID. Vaccination history included: Bnt162b2 (Dose number unknown, Patient thought he had had three previous immunization with Pfizer covid-19 vaccine, but was not sure), for covid-19 immunisation. The following information was reported: DYSPHAGIA (non-serious) with onset Dec2024, outcome "recovered", described as "had a lot of troubles swallowing". The event "had a lot of troubles swallowing" required emergency room visit. Therapeutic measures were not taken as a result of dysphagia. Additional information: The patient did not receive any other vaccine administered on the same day as the Pfizer Covid-19 Vaccine. When probed if consumer took any vaccine 4 weeks prior taking the Pfizer Covid-19 Vaccine, patient stated that all the vaccines the patient took were from Pfizer. Patient mentioned that he took a shot of the COVID-19 (it was just a normal dose ) and then after that he had a lot of troubles swallowing in December of 2024 for about 6 hours and it did not go totally away for about 2 days. It got better over the next two days and it was totally gone after two days. Patient had had lab test but not for this. For this patient almost went for emergency room but now with no treatment. The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.
Blood pressure high
ALDACTONE [SPIRONOLACTONE]; PREVACID